Why Medicare price negotiations matter for Novo Nordisk, AstraZeneca, and other European pharma companies
found
Pharma companies are facing pricing pressure from several directions, including from the U.S. Medicare negotiations
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
AstraZeneca
since
auto-detected in 57 stories
10 days ago
33 days ago
AstraZeneca wins shareholder approval for New York listing ⊕⊕
found
a story from Financial Times ✅ › Financial Times
Move by FTSE’s biggest company gains support of 99% of shareholders who voted in blow to London market
56 days ago
AstraZeneca agrees deal with Trump to lower drug prices for US patients - as NHS faces rocketing bill
found
a story from The Daily Mail 💩 › The Daily Mail
The British-Swedish company will now charge a 'Most Favored Nation' rate, matching the lowest price offered to other wealthy nations, to Medicaid.
AstraZeneca makes deal with Trump to lower drug prices and avoid tariffs
found
a story from The Guardian ⚠️ › International
Company to sell some medicines at a discount to US’s Medicaid health plan in exchange for tariff relief
Donald Trump announced a deal with the British-based drugmaker AstraZeneca for a “most-favored-n…
57 days ago
Trump reveals prescription drug deal with pharmaceutical giant AstraZeneca ⊖
The US president told reporters he didn't think the deal would have been possible without his 100-percent tariff threat.
Trump reaches deal with AstraZeneca to lower U.S. drug prices, MSNBC reports
Trump is set to announce the agreement with AstraZeneca on Friday, after striking a similar deal with Pfizer late last month.
60 days ago
AstraZeneca heaps pressure on Keir Starmer with threat to slash investment in the UK unless NHS accepts higher drugs prices
found
a story from The Daily Mail 💩 › The Daily Mail
Shaun Grady told an event at the Conservative Party Conference that Britain's pricing regime, which seeks to limit the financial impact on the health service, was 'appalling'.
65 days ago
AstraZeneca’s US listing to leave £200mn UK stamp duty hole ⊕
HMRC will no longer reap benefit of share trading in FTSE 100’s largest company
66 days ago
Diversified Energy to switch its primary listing from London to New York
found
a story from Financial Times ✅ › Financial Times
City of London suffers fresh setback days after AstraZeneca said it would list its shares directly on the NYSE
CNBC's UK Exchange newsletter: AstraZeneca gets a shot on Wall Street
found
The British government should not get complacent about AstraZeneca's U.S. listing, as it paves the way for a full one in New York.